The story of Sildenafil presents a complex picture for those considering investment. While the initial launch generated substantial returns, the lapse of its exclusive rights opened the door to generic versions, https://bookmarkingace.com/story21659791/sildenafil-and-the-pharmaceutical-industry-a-volatile-opportunity